Stuart Farrow

7.9k total citations · 2 hit papers
72 papers, 6.2k citations indexed

About

Stuart Farrow is a scholar working on Immunology, Molecular Biology and Physiology. According to data from OpenAlex, Stuart Farrow has authored 72 papers receiving a total of 6.2k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Immunology, 25 papers in Molecular Biology and 17 papers in Physiology. Recurrent topics in Stuart Farrow's work include Immune Response and Inflammation (18 papers), Asthma and respiratory diseases (16 papers) and NF-κB Signaling Pathways (12 papers). Stuart Farrow is often cited by papers focused on Immune Response and Inflammation (18 papers), Asthma and respiratory diseases (16 papers) and NF-κB Signaling Pathways (12 papers). Stuart Farrow collaborates with scholars based in United Kingdom, United States and India. Stuart Farrow's co-authors include Robin Brown, David Ray, Andrew Loudon, Allard Kaptein, Julie Gibbs, Thomas Raven, Kwok‐Tao Pun, Laura Matthews, Simon Plummer and Karen Holloway and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Nucleic Acids Research.

In The Last Decade

Stuart Farrow

72 papers receiving 6.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Inhibition of cyclo-oxygenase 2 expression in colon cells by the chemopreventive agent curcumin involves inhibition of NF-κB activation via the NIK/IKK signalling complex

1999 539 citations Simon Plummer, Karen Holloway et al. Oncogene profile →
The nuclear receptor REV-ERBα mediates circadian regulation of innate immunity through selective regulation of inflammatory cytokines

2011 527 citations Julie Gibbs, John Blaikley et al. Proceedings of the National Academy of Sciences profile →

Peers

Countries citing papers authored by Stuart Farrow

Since Specialization

Citations

This map shows the geographic impact of Stuart Farrow's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stuart Farrow with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stuart Farrow more than expected).

Fields of papers citing papers by Stuart Farrow

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stuart Farrow. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stuart Farrow. The network helps show where Stuart Farrow may publish in the future.

Co-authorship network of co-authors of Stuart Farrow

This figure shows the co-authorship network connecting the top 25 collaborators of Stuart Farrow. A scholar is included among the top collaborators of Stuart Farrow based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stuart Farrow. Stuart Farrow is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	MAP3K8 is a potential therapeutic target in airway epithelial inflammation 2024 ·Journal of Inflammation ·Chih‐Yung Chiu, Saffron A.G. Willis‐Owen, Kenny Wong, Stuart Farrow, William Cookson, Miriam F. Moffatt, Youming Zhang	2
2	Glucocorticoids impair type I IFN signalling and enhance rhinovirus replication 2020 ·European Journal of Pharmacology ·(unknown), Dawid Swieboda, Anabel Guedán, Stuart Farrow, Paolo Casolari, Marco Contoli, Sebastian L. Johnston, Alberto Papi, Roberto Solari	16
3	Death Receptor 3 regulates distinct pathological attributes of acute versus chronic murine allergic lung inflammation 2017 ·Cellular Immunology ·Ravinder Singh, (unknown), Jason P. Twohig, Emma J. Kidd, Kenneth J. Broadley, Stuart Farrow, Anwen S. Williams, Philip R. Taylor, Eddie C. Y. Wang	4
4	PAK proteins and YAP-1 signalling downstream of integrin beta-1 in myofibroblasts promote liver fibrosis 2016 ·Nature Communications ·Katherine J. Martin, James Pritchett, Jessica Llewellyn, Aoibheann Mullan, Varinder Athwal, Ross Dobie, Emma Harvey, Leo Zeef, Stuart Farrow, Charles Streuli, Neil C. Henderson, Scott L. Friedman, Neil A. Hanley, Karen Piper Hanley	167
5	An epithelial circadian clock controls pulmonary inflammation and glucocorticoid action 2014 ·Nature Medicine ·Julie Gibbs, Louise M. Ince, Laura Matthews, Junjie Mei, Thomas Bell, Nan Yang, Ben Saer, Nicola Begley, Toryn Poolman, Marie Pariollaud, Stuart Farrow, Francesco J. DeMayo, Tracy Hussell, G. Scott Worthen, David Ray, Andrew Loudon	332
6	The Methyltransferase WBSCR22/Merm1 Enhances Glucocorticoid Receptor Function and Is Regulated in Lung Inflammation and Cancer 2014 ·Journal of Biological Chemistry ·Maryam Jangani, Toryn Poolman, Laura Matthews, Nan Yang, Stuart Farrow, Andrew Berry, Neil A. Hanley, Andrew J.K. Williamson, Anthony D. Whetton, Rachelle Donn, David Ray	34
7	The nuclear receptor REV-ERBα mediates circadian regulation of innate immunity through selective regulation of inflammatory cytokines breakdown → 2011 ·Proceedings of the National Academy of Sciences ·Julie Gibbs, John Blaikley, Stephen Beesley, Laura Matthews, Karen D. Simpson, (unknown), Stuart Farrow, Kathryn J. Else, (unknown), David Ray, Andrew Loudon	527
8	A New Strategy for the Identification of Novel Molecules with Targeted Proresolution of Inflammation Properties 2009 ·The Journal of Immunology ·(unknown), Justine Newson, Vera L.F. Silveira, Stuart Farrow, Derek W. Gilroy, Jonas Byström	84
9	Treatment with a peroxisomal proliferator activated receptor gamma agonist has a modest effect in the allergen challenge model in asthma: A randomised controlled trial 2009 ·Respiratory Medicine ·Duncan Richards, Philippe Bareille, (unknown), Dean Quinn, Stuart Farrow	43
10	The effects of dexamethasone on cigarette smoke induced gene expression changes in COPD macrophages 2009 ·International Immunopharmacology ·(unknown), (unknown), Stuart Farrow, Dave Singh	17
11	Resolution-phase macrophages possess a unique inflammatory phenotype that is controlled by cAMP 2008 ·Blood ·Jonas Byström, Ian Evans, Justine Newson, Melanie Stables, Iqbal Toor, Nico van Rooijen, Mark Crawford, Paul Colville‐Nash, Stuart Farrow, Derek W. Gilroy	259
12	Liver X Receptor Agonists Increase Airway Reactivity in a Model of Asthma via Increasing Airway Smooth Muscle Growth 2008 ·The Journal of Immunology ·Mark A. Birrell, Jorge De Alba, Matthew C. Catley, Elizabeth Hardaker, Sissie Wong, Michael P. Collins, Deborah Clarke, Stuart Farrow, Timothy M. Willson, Jon L. Collins, Maria G. Belvisi	23
13	Estrogen Receptor β: Expression Profile and Possible Anti-Inflammatory Role in Disease 2008 ·Journal of Pharmacology and Experimental Therapeutics ·Matthew C. Catley, Mark A. Birrell, Elizabeth Hardaker, Jorge De Alba, Stuart Farrow, Saleem Haj‐Yahia, Maria G. Belvisi	25
14	Novel Role for the Liver X Nuclear Receptor in the Suppression of Lung Inflammatory Responses 2007 ·Journal of Biological Chemistry ·Mark A. Birrell, Matthew C. Catley, Elizabeth Hardaker, Sissie Wong, Timothy M. Willson, Kerryn McCluskie, Thomas B. Leonard, Stuart Farrow, Jon L. Collins, Saleem Haj‐Yahia, Maria G. Belvisi	53
15	The Relationship between Intranuclear Mobility of the NF-κB Subunit p65 and Its DNA Binding Affinity 2006 ·Journal of Biological Chemistry ·Marcel J. M. Schaaf, (unknown), B. P. Hayes, Barbara Maschera, Eleni Stylianou, Stuart Farrow	22
16	A pharmacological approach to enhancing the therapeutic index of corticosteroids in airway inflammatory disease 2005 ·Current Opinion in Pharmacology ·Iain Uings, Stuart Farrow	15
17	Glucocorticoid Ligands Specify Different Interactions with NF-κB by Allosteric Effects on the Glucocorticoid Receptor DNA Binding Domain 2004 ·Journal of Biological Chemistry ·Helen Garside, Adam Stevens, Stuart Farrow, Claire Normand, Benoit Houle, Andrew Berry, Barbara Maschera, David Ray	96
18	Prostaglandin D2 and Its Metabolites Induce Caspase-Dependent Granulocyte Apoptosis That Is Mediated Via Inhibition of IκBα Degradation Using a Peroxisome Proliferator-Activated Receptor-γ-Independent Mechanism 2002 ·The Journal of Immunology ·Carol Ward, Ian Dransfield, Joanna Murray, Stuart Farrow, Christopher Haslett, Adriano G. Rossi	107
19	Inhibition of cyclo-oxygenase 2 expression in colon cells by the chemopreventive agent curcumin involves inhibition of NF-κB activation via the NIK/IKK signalling complex breakdown → 1999 ·Oncogene ·Simon Plummer, Karen Holloway, Margaret M. Manson, R. J. L. Munks, Allard Kaptein, Stuart Farrow, Lynne Howells	539
20	Duplication of theDR3Gene on Human Chromosome 1p36 and Its Deletion in Human Neuroblastoma 1998 ·Genomics ·José Grenet, Virginia Valentine, Jeremy Kitson, (unknown), Stuart Farrow, Vincent J. Kidd	25

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact